CHICAGO, IL, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Epazz, Inc. (OTC: EPAZ), is pleased to announce that it is developing HIPAA (Health Insurance Portability and Accountability Act of 1996)-compliant electronic medical record software based on its MSHealth software platform using its blockchain storage technology to become a market leader in the U.S. medical marijuana market, which is expected to grow to $8 billion by 2024 according to Global Market Insight.
The software will initially be marketed in Canada. The blockchain storage technology will offer patients the ability to control their data and send it to different health care providers for their medical marijuana prescriptions.
According to Epazz CEO, Shaun Passley, Ph.D., “We are extending our state-of-the-art technology in different vertical markets to maximize its value. We expect to grab a significant market share at the onset as our blockchain storage will change how patients control their medical data. Our advanced blockchain technology provides a competitive edge which will allow us to dramatically grow revenues.”
About Epazz, Inc. (www.epazz.com)
Epazz, Inc., is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher education institutions and the public sector. Epazz BoxesOS™ v3.0 is the complete business web-based software package for small to midsize businesses, Fortune 500 enterprises, government agencies and higher education institutions. BoxesOS provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz’s other products are DeskFlex™ (hoteling software) and Provitrac™ (an applicant-tracking system).
SAFE HARBOR
This is the “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of forward-looking statements such as “may,” “expect,” “intend,” “estimate,” “anticipate,” “believe” and “continue” (or the negative thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that any forward-looking statements are not guarantees of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz, Inc. assumes no obligation and has no intention of updating these forward-looking statements, and it has no obligation to update or correct information prepared by third parties that is not paid for by Epazz, Inc. Investors are encouraged to review Epazz, Inc.’s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC markets filings, which contain general business information about the company’s operations, results of operations and risks associated with the company and its operations.